Use of Poloxamers for Deswelling of Organ-Cultured Corneas

Abstract

Dextran T500, routinely used as a deswelling supplement in organ culture (OC), has been suspected of being toxic to corneal endothelial cells (ECs). This study was conducted to evaluate the innovative use of poloxamers compared with dextran for deswelling OC corneas. Five poloxamers (P124, P188, P237, P338, and P407) were dissolved respectively in a standard OC medium to reach 350 mOsmol/kg. In vitro cytotoxicity of these media was tested by MTT assay on human corneal epithelial and endothelial cell lines and on primary human corneal fibroblasts. Paired human corneas stored in OC for at least 21 days were assigned for 48 hours to a poloxamer medium or to a standard deswelling medium containing 5% dextran T500. Corneal EC density, morphometry, visualization, mortality, stromal thickness, transparency, and folding were evaluated before and after deswelling. Corneas were finally cut into three parts for histologic and ultrastructural observation. Besides similar corneal transparency improvement and thickness deswelling, poloxamers (except P124) reduced EC loss and facilitated endothelial visualization, but improved stromal folding less than dextran. The similar ultrastructures observed in the two groups were epithelial shedding, normal collagen fiber diameter and organization, uptake of deswelling agents by ECs, vacuolization but normal organelles in ECs and keratocytes, and endothelial surface modifications. P188, P237, P338, and P407 performed similarly in preserving ECs, improving EC visualization, deswelling corneal stroma and inducing moderate injuries to corneal ultrastructure. They appear superior to dextran for corneal deswelling in OC.